The discrepancy may reflect that the second-order mode has been shown to reliably track DAT abundance in the striatum, but studies of psychosis have focused on dopaminergic synthesis capacity, as measured using 3,4-dihydroxy-6-[18 F]-fluoro-L-phenylalanine ([18 F]DOPA). The gene discussed is SLC6A3; the disease is psychotic disorder.